# Adjunctive iTBS for First-Episode Schizophrenia

> **NCT07116850** · NA · COMPLETED · sponsor: **The First Hospital of Hebei Medical University** · enrollment: 100 (actual)

## Conditions studied

- Schizophrenia Disorder

## Interventions

- **DEVICE:** Intermittent Theta-Burst Stimulation (iTBS)
- **DRUG:** Risperidone
- **BEHAVIORAL:** Cognitive Behavioral Therapy (CBT)

## Key facts

- **NCT ID:** NCT07116850
- **Lead sponsor:** The First Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116850, "Adjunctive iTBS for First-Episode Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07116850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*